Effects of a Single Escape Mutation on T Cell and HIV-1 Co-adaptation
Xiaoming Sun,
Yi Shi,
Tomohiro Akahoshi,
Mamoru Fujiwara,
Hiroyuki Gatanaga,
Christian Schönbach,
Nozomi Kuse,
Victor Appay,
George F. Gao,
Shinichi Oka,
Masafumi Takiguchi
Affiliations
Xiaoming Sun
Center for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
Yi Shi
Chinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
Tomohiro Akahoshi
Center for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
Mamoru Fujiwara
Center for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
Hiroyuki Gatanaga
Center for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
Christian Schönbach
Center for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
Nozomi Kuse
Center for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
Victor Appay
International Research Center of Medical Sciences (IRCMS), Kumamoto University, Kumamoto 860-0811, Japan
George F. Gao
Chinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
Shinichi Oka
Center for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
Masafumi Takiguchi
Center for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
The mechanistic basis for the progressive accumulation of Y135F Nef mutant viruses in the HIV-1-infected population remains poorly understood. Y135F viruses carry the 2F mutation within RW8 and RF10, which are two HLA-A∗24:02-restricted superimposed Nef epitopes recognized by distinct and adaptable CD8+ T cell responses. We combined comprehensive analysis of the T cell receptor repertoire and cross-reactive potential of wild-type or 2F RW8- and RF10-specific CD8+ T cells with peptide-MHC complex stability and crystal structure studies. We find that, by affecting direct and water-mediated hydrogen bond networks within the peptide-MHC complex, the 2F mutation reduces both TCR and HLA binding. This suggests an advantage underlying the evolution of the 2F variant with decreased CD8+ T cell efficacy. Our study provides a refined understanding of HIV-1 and CD8+ T cell co-adaptation at the population level.